Literature DB >> 11106298

The feline model of neuroAIDS: understanding the progression towards AIDS dementia.

M Podell1, P A March, W R Buck, L E Mathes.   

Abstract

Feline immunodeficiency virus (FIV) is a neurotropic lentivirus that produces a protracted state of immunodeficiency and encephalopathy in the cat. Recent evidence has shown several similarities to the natural progression of human immunodeficiency virus infection (HIV-1) associated degenerative effects on the central and peripheral nervous systems. Similar to HIV-1, FIV-induced encephalopathy neurovirulence is strain dependent, results in progressive immunodeficiency and increasing early peripheral but not brain viral load, preferentially affects the developing nervous system, produces quantifiable behavioural and neurophysiological impairment that is not directly linked to neuronal infectivity, and induces neuronal injury and loss both in vivo and in vitro. This paper highlights the cumulative scientific body of evidence supporting the use of the feline model of neuroAIDS.

Entities:  

Mesh:

Year:  2000        PMID: 11106298     DOI: 10.1177/026988110001400303

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  19 in total

1.  Phylogenetic analyses of Texas isolates indicate an evolving subtype of the clade B feline immunodeficiency viruses.

Authors:  Eric A Weaver; Ellen W Collisson; Margaret Slater; Guan Zhu
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Neurovirulence depends on virus input titer in brain in feline immunodeficiency virus infection: evidence for activation of innate immunity and neuronal injury.

Authors:  J B Johnston; C Silva; T Hiebert; R Buist; M R Dawood; J Peeling; C Power
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

3.  Strain-specific viral distribution and neuropathology of feline immunodeficiency virus.

Authors:  Craig Miller; Helle Bielefeldt-Ohmann; Martha MacMillan; Salvador Huitron-Resendiz; Steven Henriksen; John Elder; Susan VandeWoude
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

4.  Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection.

Authors:  Greg Brennan; Michael D Podell; Raymund Wack; Susan Kraft; Jennifer L Troyer; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

Review 5.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

6.  High resolution MRI anatomy of the cat brain at 3 Tesla.

Authors:  Heather L Gray-Edwards; Nouha Salibi; Eleanor M Josephson; Judith A Hudson; Nancy R Cox; Ashley N Randle; Victoria J McCurdy; Allison M Bradbury; Diane U Wilson; Ronald J Beyers; Thomas S Denney; Douglas R Martin
Journal:  J Neurosci Methods       Date:  2014-02-10       Impact factor: 2.390

Review 7.  Animal models for HIV/AIDS research.

Authors:  Theodora Hatziioannou; David T Evans
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

8.  Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes.

Authors:  Mikhail A Gavrilin; Lawrence E Mathes; Michael Podell
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

Review 9.  Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.

Authors:  Christopher Power
Journal:  J Neurovirol       Date:  2017-12-15       Impact factor: 2.643

10.  Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease.

Authors:  Allison M Bradbury; Heather L Gray-Edwards; Jamie L Shirley; Victoria J McCurdy; Alexandria N Colaco; Ashley N Randle; Pete W Christopherson; Allison C Bird; Aime K Johnson; Diane U Wilson; Judith A Hudson; Nicholas L De Pompa; Donald C Sorjonen; Brandon L Brunson; Mylvaganam Jeyakumar; Frances M Platt; Henry J Baker; Nancy R Cox; Miguel Sena-Esteves; Douglas R Martin
Journal:  Exp Neurol       Date:  2014-10-05       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.